List of insiders holdings for Eidos Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Kumar Neil Chief Executive Officer 10% Owner | 2019-07-08 21:32:17 | 0 24,575,501 | 24,575,501 | Form 4 |
| 2 | RA CAPITAL MANAGEMENT LLC RA Capital Healthcare Fund LP Kolchinsky Peter Director | 2020-10-07 17:00:21 | 1,798,339 0 | 1,798,339 | Form 13D |
| 3 | Siu Christine CFO and Secretary | 2019-12-11 16:44:56 | 188,661 0 | 188,661 | Form 4 |
| 4 | Huh Hoyoung Director | 2018-06-22 18:55:33 | 83,750 0 | 83,750 | Form 4 |
| 5 | Shah Rajeev M. Director | 2020-05-29 16:06:02 | 21,528 0 | 21,528 | Form 4 |
| 6 | AGUIAR ERIC Director | 2020-05-29 16:08:21 | 21,528 0 | 21,528 | Form 4 |
| 7 | BridgeBio Pharma Inc. 10% Owner | 2021-01-26 16:05:09 | 1000 0 | 1000 | Form 4 |
| 8 | Sinha Uma Chief Scientific Officer | 2021-01-28 19:00:37 | 0 0 | 0 | Form 4 |
| 9 | Hooper Suzanne Sawochka Director | 2021-01-28 19:04:04 | 0 0 | 0 | Form 4 |
| 10 | Lis William Director | 2021-01-28 19:06:52 | 0 0 | 0 | Form 4 |
| 11 | Satvat Ali J. Director | 2021-01-28 19:08:33 | 0 0 | 0 | Form 4 |
| 12 | Turtle Cameron Chief Business Officer | 2021-01-28 19:15:48 | 0 0 | 0 | Form 4 |
| 13 | Valle Franco Senior Vice President, Finance | 2021-01-28 19:22:38 | 0 0 | 0 | Form 4 |
| 14 | Rohlen Douglas Director | 2021-01-28 19:39:25 | 0 0 | 0 | Form 4 |
| 15 | Fox Jonathan C See Remarks | 2021-01-28 19:50:50 | 0 0 | 0 | Form 4 |